Yun Jeong Oh

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells

Nam-Gu Her, Jeong-Woo Oh, Yun Jeong Oh et al. · Cell Death and Disease · 2018 · 66 citations · Full text

Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib

Sung‐Eun Lee, Soo Young Choi, Ju‐Hee Bang et al. · American Journal of Hematology · 2013 · 56 citations · Full text

Hematological Malignancy, Transplantation, Oncology +15

The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate

Sung‐Eun Lee, Soo Young Choi, Ju‐Hee Bang et al. · Cancer Genetics · 2012 · 25 citations

Clonal Chromosomal Abnormalities, Chromatin, Long-term Clinical Implications +13

The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling

Suji Han, Hyemi Shin, Jeong-Woo Oh et al. · Cancers · 2019 · 23 citations · Full text

Neuro-oncology, Akt Signaling, Glioma +13

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

Ji Hyung Hong, Sung‐Eun Lee, Soo Young Choi et al. · Cancer Research and Treatment · 2014 · 20 citations · Full text